Delivery Order SPE2DB22D2005-SPE2DB25FJJM8

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $1,001.41 to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565320971 - LIDOCAINE 5% PATCH 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities, including...
The U.S. Defense Logistics Agency (DLA) awarded a $4,075.79 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 4565733878 - LIDOCAINE 5% PATCH 30S, with a performance period ending on September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a $1,186.46 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of 4565597607 - LIDOCAINE 5% PATCH 30S. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $9,239.62 delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565678797 ! LIDOCAINE 5% PATCH 30S. This delivery order was issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a $1,109.75 delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA) for the supply of 4565735143 - LIDOCAINE 5% PATCH 30S. The delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,158.41 firm fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has an ultimate completion date of December 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
The U.S. government awarded a delivery order contract worth $1,034.40 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of 4565673717 LIDOCAINE 5% PATCH 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
This is a $7,891.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4564786678 LIDOCAINE 5% PATCH 30S, a medical product, with a performance period through June 4, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,168.77 firm fixed-price contract is for the supply of 4565667882 - LIDOCAINE 5% PATCH 30S, with a period of performance through September 4, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a firm fixed price ceiling of $7,890.45 and a completion date of February 6, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJJM8
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,744.98 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567523000 LIDOCAINE 5% PATCH 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. The contract does not have a set-aside designation, indicating open competition.

Generated 6/9/25, 9:45 AM